AI English summary of an SEC filing — figures as filed
Thermo Fisher Scientific TMOThe company said revenue for Q3 2026 rose 9% to $12.14 billion from $11.12 billion a year earlier, and organic revenue growth was 6%.
Key points
AI summaryThe company said revenue for Q3 2026 rose 9% to $12.14 billion from $11.12 billion a year earlier, and organic revenue growth was 6%.
Thermo Fisher said GAAP diluted EPS for Q3 rose 9% to $4.64, adjusted EPS rose 15% to $6.68, and GAAP operating margin was 18.6%, compared with 17.4% a year earlier.
The company said adjusted operating income for Q3 was $2.97 billion, 15% higher than a year earlier, and adjusted operating margin was 24.5%, compared with 23.3% a year earlier.
Thermo Fisher reported that net cash provided by operating activities for the 9 months ended 2026 was $5,867 million, and free cash flow (non-GAAP) was $4,618 million, compared with $3,319 million a year earlier.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Q3 Revenue $12.14 billion, Organic Growth 6%
The company said revenue for Q3 2026 rose 9% to $12.14 billion from $11.12 billion a year earlier, and organic revenue growth was 6%.
Source · Based on the filing body and exhibits
Q3 GAAP and Adjusted Earnings Metrics
Thermo Fisher said GAAP diluted EPS for Q3 rose 9% to $4.64, adjusted EPS rose 15% to $6.68, and GAAP operating margin was 18.6%, compared with 17.4% a year earlier.
Source · Based on the filing body and exhibits
Q3 Adjusted Operating Income and Margin
The company said adjusted operating income for Q3 was $2.97 billion, 15% higher than a year earlier, and adjusted operating margin was 24.5%, compared with 23.3% a year earlier.
Source · Based on the filing body and exhibits
9-Month Operating Cash Flow and Free Cash Flow
Thermo Fisher reported that net cash provided by operating activities for the 9 months ended 2026 was $5,867 million, and free cash flow (non-GAAP) was $4,618 million, compared with $3,319 million a year earlier.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…